Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study
Xi Xiong, Carlos King Ho Wong, Ivan Chi Ho Au, et al.
Thyroid (2022) Vol. 32, Iss. 5, pp. 505-514
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Thyroid dysfunction in COVID-19
David Tak Wai Lui, Chi‐Ho Lee, Yu Cho Woo, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 6, pp. 336-348
Closed Access | Times Cited: 15
Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study
Francisco Tsz Tsun Lai, Gilbert T. Chua, Edward W. Chan, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 885-893
Open Access | Times Cited: 51
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study
Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2304-2314
Open Access | Times Cited: 44
Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines
Carlos King Ho Wong, Lung‐Yi Mak, Ivan Chi Ho Au, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 5, pp. 1339-1348
Open Access | Times Cited: 42
Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns
Dimitra S. Mouliou, Efthimios Dardiotis
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1555-1555
Open Access | Times Cited: 39
Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19
Eric Yuk Fai Wan, Vincent Ka Chun Yan, Anna Hoi Ying Mok, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 4, pp. 505-514
Open Access | Times Cited: 33
Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study
Carlos King Ho Wong, Kristy T. K. Lau, Xi Xiong, et al.
PLoS Medicine (2022) Vol. 19, Iss. 6, pp. e1004018-e1004018
Open Access | Times Cited: 33
Association of SARS-CoV-2 Vaccination or Infection With Bell Palsy
Ali Rafati, Yeganeh Pasebani, Melika Jameie, et al.
JAMA Otolaryngology–Head & Neck Surgery (2023) Vol. 149, Iss. 6, pp. 493-493
Open Access | Times Cited: 20
Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study
Xi Xiong, David Tak Wai Lui, Matthew S. H. Chung, et al.
PLoS Medicine (2023) Vol. 20, Iss. 7, pp. e1004274-e1004274
Open Access | Times Cited: 19
Post-acute sequelae of hospitalised COVID-19 re-infection compared with hospitalised first-time infection: a population-based retrospective cohort study in Hong Kong
Vincent Ka Chun Yan, Yin Zhang, Deliang Yang, et al.
BMJ Public Health (2025) Vol. 3, Iss. 1, pp. e000833-e000833
Open Access
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong
Xue Li, Le Gao, Xinning Tong, et al.
Journal of Autoimmunity (2022) Vol. 130, pp. 102830-102830
Open Access | Times Cited: 25
Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients
Carlos King Ho Wong, David Tak Wai Lui, Xi Xiong, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature
Letizia Chiara Pezzaioli, Elisa Gatta, Francesca Bambini, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 22
Distinct Clinical Features of Post-COVID-19 Vaccination Early-onset Graves’ Disease
Luigi di Filippo, Laura Castellino, Agnese Allora, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 1, pp. 107-113
Open Access | Times Cited: 18
Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study
Vincent Ka Chun Yan, Franco Wing Tak Cheng, Celine Sze Ling Chui, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Population-Based Clinical Studies Using Routinely Collected Data in Hong Kong, China: A Systematic Review of Trends and Established Local Practices
Derek Wu, Ronald Hang Kin Nam, Keith Sai Kit Leung, et al.
Cardiovascular Innovations and Applications (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Effect of COVID-19 Vaccines on Thyroid Function and Autoimmunity and Effect of Thyroid Autoimmunity on Antibody Response
David Tak Wai Lui, Chi‐Ho Lee, Chloe Y. Y. Cheung, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 9, pp. e3781-e3789
Open Access | Times Cited: 16
Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization
Carlos King Ho Wong, Xi Xiong, Kristy T. K. Lau, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 14
COVID-19 vaccine effectiveness against the Omicron variant of SARS-CoV-2 in multimorbidity: A territory-wide case-control study
Francisco Tsz Tsun Lai, Vincent Ka Chun Yan, Eric Yuk Fai Wan, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109428-109428
Open Access | Times Cited: 2
Comparison of safety and efficacy between Nirmatrelvir-ritonavir and molnupiravir in the treatment of COVID-19 infection in patients with advanced kidney disease: a retrospective observational study
Wing Ming Chu, Eric Yuk Fai Wan, Zoey Cho Ting Wong, et al.
EClinicalMedicine (2024) Vol. 72, pp. 102620-102620
Open Access | Times Cited: 2
Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination With BNT162b2 Increased Risk of Bell’s Palsy: A Nested Case-Control and Self-Controlled Case Series Study
Eric Yuk Fai Wan, Celine Sze Ling Chui, V Ng, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e291-e298
Open Access | Times Cited: 13
Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case–control study
Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, et al.
Journal of Travel Medicine (2022) Vol. 29, Iss. 8
Open Access | Times Cited: 13
Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study
Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Effect of Inactivated and mRNA COVID-19 Vaccination on Thyroid Function Among Patients Treated for Hyperthyroidism
Chun Ho Wong, Eunice Ka Hong Leung, Lawrence Chi Kin Tang, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 5, pp. e76-e88
Open Access | Times Cited: 9
Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID‐19 patients with type 2 diabetes: A target trial emulation study
Eric Yuk Fai Wan, Zoey C. T. Wong, Vincent Ka Chun Yan, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4653-4664
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top